Status:
COMPLETED
Endoscopic Versus Percutaneous Biliary Drainage for Resectable Pancreatic Head Cancer
Lead Sponsor:
Hani Alhadad
Conditions:
Pancreatic Head Cancer
Obstructive Jaundice
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Patients with potentially resectable pancreatic head cancer and high bilirubin level, were stratified into two equal groups according to the method of biliary drainage: endoscopic stenting or percutan...
Detailed Description
Along with history taking and complete clinical examination, the results of complete blood count, international normalized ratio , renal and liver function tests were obtained. Patients with coagulopa...
Eligibility Criteria
Inclusion
- Patients with malignant obstruction of the distal common bile duct e.g. adenocarcinoma of the pancreatic head or periampullary tumor
- Hyperbilirubinemia, total bilirubin level more than 10 mg/dL
- Cholangitis, pruritis, coagulopathy, nausea and anorexia
Exclusion
- Patients with advanced disease
- metastatic disease
- Patients undergoing neoadjuvant therapy
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04823832
Start Date
January 1 2019
End Date
December 31 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Alexandria, Egypt